Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur David COHEN |
Documents disponibles écrits par cet auteur (34)
Faire une suggestion Affiner la recherche
Reliability and diagnostic efficiency of the Diagnostic Inventory for Disharmony (DID) in youths with Pervasive Developmental Disorder and Multiple Complex Developmental Disorder / Jean XAVIER in Research in Autism Spectrum Disorders, 5-4 (October-December 2011)
[article]
Titre : Reliability and diagnostic efficiency of the Diagnostic Inventory for Disharmony (DID) in youths with Pervasive Developmental Disorder and Multiple Complex Developmental Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Jean XAVIER, Auteur ; Léonard VANNETZEL, Auteur ; Sylvie VIAUX, Auteur ; Arthur LEROY, Auteur ; Monique PLAZA, Auteur ; Sylvie TORDJMAN, Auteur ; Christian MILLE, Auteur ; Claude BURSZTEJN, Auteur ; David COHEN, Auteur ; Jean-Marc GUILE, Auteur Année de publication : 2011 Article en page(s) : p.1493-1499 Langues : Anglais (eng) Mots-clés : PDD-NOS Multiple Complex Developmental Disorder Disharmony Concordance Validity Index. décimale : PER Périodiques Résumé : The Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) category is a psychopathological entity few have described and is poorly, and mainly negatively, defined by autism exclusion. In order to limit PDD-NOS heterogeneity, alternative clinical constructs have been developed. This study explored the reliability and the diagnostic efficiency of the Diagnostic Inventory for Disharmony (DID); its concurrent validity with the Vineland Adaptive Behavior Scales (VBAS); and its concordance with Multiplex Complex Developmental Disorder (MCDD) and PDD-NOS. Mean DID interrater reliabilities and internal consistency were good (.58 and .75, respectively). DID diagnostic efficiency yielded by the ROC analysis was very promising using a cut-off score of 12/36 (AUC = .97, sensitivity = .93, specificity = .91). Spearman correlations between the DID total score and the three subscales in the VABS socialization domain were significantly negative, thus confirming an association between Disharmony and impairments in socialization. However, no correlation was found between Disharmony and community daily living skills, likely reflecting a better autonomy in daily activities. Disharmony phenomenology overlapped with Autism Spectrum Disorders (DID and PDD concordance: kappa: .41; p < .01). Nevertheless, the Disharmony construct seemed to differ from PDD-NOS and be closer to MCDD. We conclude that Disharmony and MCDD constitute complementary views on the same group of severely impaired children. En ligne : http://dx.doi.org/10.1016/j.rasd.2011.02.010 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=126
in Research in Autism Spectrum Disorders > 5-4 (October-December 2011) . - p.1493-1499[article] Reliability and diagnostic efficiency of the Diagnostic Inventory for Disharmony (DID) in youths with Pervasive Developmental Disorder and Multiple Complex Developmental Disorder [Texte imprimé et/ou numérique] / Jean XAVIER, Auteur ; Léonard VANNETZEL, Auteur ; Sylvie VIAUX, Auteur ; Arthur LEROY, Auteur ; Monique PLAZA, Auteur ; Sylvie TORDJMAN, Auteur ; Christian MILLE, Auteur ; Claude BURSZTEJN, Auteur ; David COHEN, Auteur ; Jean-Marc GUILE, Auteur . - 2011 . - p.1493-1499.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 5-4 (October-December 2011) . - p.1493-1499
Mots-clés : PDD-NOS Multiple Complex Developmental Disorder Disharmony Concordance Validity Index. décimale : PER Périodiques Résumé : The Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) category is a psychopathological entity few have described and is poorly, and mainly negatively, defined by autism exclusion. In order to limit PDD-NOS heterogeneity, alternative clinical constructs have been developed. This study explored the reliability and the diagnostic efficiency of the Diagnostic Inventory for Disharmony (DID); its concurrent validity with the Vineland Adaptive Behavior Scales (VBAS); and its concordance with Multiplex Complex Developmental Disorder (MCDD) and PDD-NOS. Mean DID interrater reliabilities and internal consistency were good (.58 and .75, respectively). DID diagnostic efficiency yielded by the ROC analysis was very promising using a cut-off score of 12/36 (AUC = .97, sensitivity = .93, specificity = .91). Spearman correlations between the DID total score and the three subscales in the VABS socialization domain were significantly negative, thus confirming an association between Disharmony and impairments in socialization. However, no correlation was found between Disharmony and community daily living skills, likely reflecting a better autonomy in daily activities. Disharmony phenomenology overlapped with Autism Spectrum Disorders (DID and PDD concordance: kappa: .41; p < .01). Nevertheless, the Disharmony construct seemed to differ from PDD-NOS and be closer to MCDD. We conclude that Disharmony and MCDD constitute complementary views on the same group of severely impaired children. En ligne : http://dx.doi.org/10.1016/j.rasd.2011.02.010 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=126 Retard mental, déficience intellectuelle / David COHEN
Titre : Retard mental, déficience intellectuelle Type de document : Texte imprimé et/ou numérique Auteurs : David COHEN, Auteur ; Daniel MARCELLI, Auteur ; Philipe MAZET, Auteur Année de publication : 2016 Importance : p.325-350 Langues : Français (fre) Index. décimale : DYS-C DYS-C - Troubles des Apprentissages - Généralités Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=411 Retard mental, déficience intellectuelle [Texte imprimé et/ou numérique] / David COHEN, Auteur ; Daniel MARCELLI, Auteur ; Philipe MAZET, Auteur . - 2016 . - p.325-350.
Langues : Français (fre)
Index. décimale : DYS-C DYS-C - Troubles des Apprentissages - Généralités Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=411 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects / David COHEN in Research in Autism Spectrum Disorders, 7-1 (January 2013)
[article]
Titre : Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects Type de document : Texte imprimé et/ou numérique Auteurs : David COHEN, Auteur ; Marie RAFFIN, Auteur ; Roberto CANITANO, Auteur ; Nicolas BODEAU, Auteur ; Olivier BONNOT, Auteur ; Didier PERISSE, Auteur ; Angèle CONSOLI, Auteur ; Claudine LAURENT, Auteur Année de publication : 2013 Article en page(s) : p.167-75 Langues : Anglais (eng) Mots-clés : Second generation antipsychotics Childhood Adolescence AutismIntellectual disability Adverse effects Meta-analysis Index. décimale : PER Périodiques Résumé : Second-generation antipsychotics (SGAs) induce frequent adverse effects in children and adolescents with each compound appearing to have a specific adverse effect profile. Aripiprazole and risperidone are FDA-approved medications for behavioral disturbances associated with autism and/or intellectual disabilities (ID) in children and adolescents. Using Bayesian meta-analysis of all relevant studies (N = 8; 18 arms; 782 patients), we aimed to calculate odds ratios (OR) or mean average effects to assess efficacy, weight gain, metabolic changes, sedation, and extra-pyramidal syndrome (EPS) of the two compounds. Reporting was incomplete to assess metabolic changes. Compared to placebo, significant treatment-related increases were observed for: CGI response with aripiprazole (OR = 6.09, 95% credible interval [2.3–12.63]) and risperidone (12.8 [5.57–27.33]); weight gain with aripiprazole (OR = 6.28 [1.64–17.12]) and risperidone (7.76 [1.88–25.2]); EPS with risperidone (OR = 3.72 [1.73–7.22]); and somnolence/sedation with aripiprazole (OR = 25.76 [1.29–112.3]) and risperidone (9.63 [3.52–22.79]). There were no significant differences between active compounds. We conclude that short term efficacy of risperidone and aripiprazole are similar for behavioral disturbances associated with autism and/or ID, and that secondary effects are frequent. More research should be conducted on metabolic changes as current literature is lacking compared to other indications in youths. En ligne : http://dx.doi.org/10.1016/j.rasd.2012.08.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=180
in Research in Autism Spectrum Disorders > 7-1 (January 2013) . - p.167-75[article] Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects [Texte imprimé et/ou numérique] / David COHEN, Auteur ; Marie RAFFIN, Auteur ; Roberto CANITANO, Auteur ; Nicolas BODEAU, Auteur ; Olivier BONNOT, Auteur ; Didier PERISSE, Auteur ; Angèle CONSOLI, Auteur ; Claudine LAURENT, Auteur . - 2013 . - p.167-75.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 7-1 (January 2013) . - p.167-75
Mots-clés : Second generation antipsychotics Childhood Adolescence AutismIntellectual disability Adverse effects Meta-analysis Index. décimale : PER Périodiques Résumé : Second-generation antipsychotics (SGAs) induce frequent adverse effects in children and adolescents with each compound appearing to have a specific adverse effect profile. Aripiprazole and risperidone are FDA-approved medications for behavioral disturbances associated with autism and/or intellectual disabilities (ID) in children and adolescents. Using Bayesian meta-analysis of all relevant studies (N = 8; 18 arms; 782 patients), we aimed to calculate odds ratios (OR) or mean average effects to assess efficacy, weight gain, metabolic changes, sedation, and extra-pyramidal syndrome (EPS) of the two compounds. Reporting was incomplete to assess metabolic changes. Compared to placebo, significant treatment-related increases were observed for: CGI response with aripiprazole (OR = 6.09, 95% credible interval [2.3–12.63]) and risperidone (12.8 [5.57–27.33]); weight gain with aripiprazole (OR = 6.28 [1.64–17.12]) and risperidone (7.76 [1.88–25.2]); EPS with risperidone (OR = 3.72 [1.73–7.22]); and somnolence/sedation with aripiprazole (OR = 25.76 [1.29–112.3]) and risperidone (9.63 [3.52–22.79]). There were no significant differences between active compounds. We conclude that short term efficacy of risperidone and aripiprazole are similar for behavioral disturbances associated with autism and/or ID, and that secondary effects are frequent. More research should be conducted on metabolic changes as current literature is lacking compared to other indications in youths. En ligne : http://dx.doi.org/10.1016/j.rasd.2012.08.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=180 Schizophrénies à début précoce / Olivier BONNOT
in Traité européen de psychiatrie et de psychopathologie de l'enfant et de l'adolescent / Pierre FERRARI
Titre : Schizophrénies à début précoce Type de document : Texte imprimé et/ou numérique Auteurs : Olivier BONNOT, Auteur ; David COHEN, Auteur Année de publication : 2013 Importance : p.377-384 Langues : Français (fre) Index. décimale : SCI-E SCI-E - Psychiatrie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=213 Schizophrénies à début précoce [Texte imprimé et/ou numérique] / Olivier BONNOT, Auteur ; David COHEN, Auteur . - 2013 . - p.377-384.
in Traité européen de psychiatrie et de psychopathologie de l'enfant et de l'adolescent / Pierre FERRARI
Langues : Français (fre)
Index. décimale : SCI-E SCI-E - Psychiatrie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=213 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Les schizophrénies à début précoce / Olivier BONNOT
Titre : Les schizophrénies à début précoce Type de document : Texte imprimé et/ou numérique Auteurs : Olivier BONNOT, Auteur ; David COHEN, Auteur Année de publication : 2011 Importance : p.270-280 Langues : Français (fre) Index. décimale : SCI-E SCI-E - Psychiatrie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=214 Les schizophrénies à début précoce [Texte imprimé et/ou numérique] / Olivier BONNOT, Auteur ; David COHEN, Auteur . - 2011 . - p.270-280.
Langues : Français (fre)
Index. décimale : SCI-E SCI-E - Psychiatrie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=214 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Le traitement intermodal visuel et verbal dans le syndrome de Turner. À propos d’un cas / Patricia DUBOIS-MURAT in Approche Neuropsychologique des Apprentissages chez l'Enfant - A.N.A.E., 106 (Février 2010)
PermalinkTraitement médicamenteux : Antipsychotiques / Olivier BONNOT
PermalinkTroubles des conduites et intersubjectivité / Jean-Marc GUILE
PermalinkTroubles intellectuels et cognitifs de l'enfant et de l'adolescent / Philippe MAZET
PermalinkTroubles du langage / David COHEN
PermalinkVery early signs of autism reported by parents include many concerns not specific to autism criteria / Vincent GUINCHAT in Research in Autism Spectrum Disorders, 6-2 (April-June 2012)
PermalinkWhat studies of family home movies can teach us about autistic infants: A literature review / Catherine SAINT-GEORGES in Research in Autism Spectrum Disorders, 4-3 (July-September 2010)
Permalink